Dr Reddys Laboratories annual gross margin
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories's gross margin was 58.51% for fiscal 2025.
View full Dr Reddys Laboratories company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | 58.51% | −0.08 pp |
| 2024 | 2024-03-31 | 58.60% | +1.95 pp |
| 2023 | 2023-03-31 | 56.65% | +3.57 pp |
| 2022 | 2022-03-31 | 53.08% | −1.24 pp |
| 2021 | 2021-03-31 | 54.32% | +0.47 pp |
| 2020 | 2020-03-31 | 53.84% | −0.36 pp |
| 2019 | 2019-03-31 | 54.20% | +0.47 pp |
| 2018 | 2018-03-31 | 53.74% | — |
Over the last five fiscal years, Dr Reddys Laboratories's gross margin increased from 53.84% to 58.51%, a change of +4.67 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗